Welcome to LookChem.com Sign In|Join Free
  • or
FMOC-DAB-OH HCL is a chemical compound that belongs to the class of FMOC-protected amino acids. It is a derivative of the amino acid 3,5-diaminobenzoic acid (DAB) with a FMOC (9-fluorenylmethoxycarbonyl) group attached to it. The HCL in its name indicates that it is in its hydrochloride salt form. FMOC-DAB-OH HCL is known for its role in protecting the amine group of the DAB amino acid, facilitating selective deprotection and manipulation during synthesis processes.

161420-87-7

Post Buying Request

161420-87-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

161420-87-7 Usage

Uses

Used in Peptide Synthesis:
FMOC-DAB-OH HCL is used as a building block for peptide synthesis, providing a means to protect the amine group of the DAB amino acid. This protection allows for selective deprotection and precise manipulation of the molecule, which is crucial for the successful synthesis of complex peptide structures.
Used in Organic Chemistry:
In the realm of organic chemistry, FMOC-DAB-OH HCL serves as a valuable starting material for the synthesis of various bioactive compounds. Its unique structure and protective capabilities make it an essential component in the creation of new organic molecules with potential applications in various fields.
Used in Pharmaceutical Industry:
FMOC-DAB-OH HCL is utilized as a starting material for the synthesis of pharmaceutical intermediates. Its role in the development of new drugs is significant, as it contributes to the formation of compounds that can be further modified and optimized for therapeutic use.

Check Digit Verification of cas no

The CAS Registry Mumber 161420-87-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,1,4,2 and 0 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 161420-87:
(8*1)+(7*6)+(6*1)+(5*4)+(4*2)+(3*0)+(2*8)+(1*7)=107
107 % 10 = 7
So 161420-87-7 is a valid CAS Registry Number.

161420-87-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Fmoc-L-alpha,gamma-diaminobutyric acid

1.2 Other means of identification

Product number -
Other names (2S)-4-amino-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:161420-87-7 SDS

161420-87-7Relevant academic research and scientific papers

Reagent-Based Diversity-Oriented Synthesis of Triazolo[1,5- A[[1,4]diazepine Derivatives from Polymer-Supported Homoazidoalanine

Králová, Petra,Soural, Miroslav

, p. 7963 - 7974 (2021)

Herein, we report the synthesis of skeletally different triazolo[1,5-a][1,4]diazepines starting from immobilized homoazidoalanine. After sulfonylation with 2/4-nitrobenzenesulfonyl chlorides and Mitsunobu alkylation with various alkynols, the corresponding N-substituted nitrobenzenesulfonamides were obtained. Their catalyst-free Huisgen cycloaddition provided immobilized and functionalized triazolo[1,5-a][1,4]diazepines as the key intermediates for further modification. Using the concept of diversity-oriented, reagent-based synthesis, the key intermediates were subsequently converted to heterocycles bearing [5 + 7 + 5], [5 + 7 + 6], and [5 + 7 + 7] scaffolds. Furthermore, the synthesis of spirocyclic triazolodiazepines was developed.

Development of Cell-Permeable, Non-Helical Constrained Peptides to Target a Key Protein–Protein Interaction in Ovarian Cancer

Wiedmann, Mareike M.,Tan, Yaw Sing,Wu, Yuteng,Aibara, Shintaro,Xu, Wenshu,Sore, Hannah F.,Verma, Chandra S.,Itzhaki, Laura,Stewart, Murray,Brenton, James D.,Spring, David R.

, p. 524 - 529 (2017)

There is a lack of current treatment options for ovarian clear cell carcinoma (CCC) and the cancer is often resistant to platinum-based chemotherapy. Hence there is an urgent need for novel therapeutics. The transcription factor hepatocyte nuclear factor

Structural evaluation of tandem hairpin pyrrole-imidazole polyamides recognizing human telomeres

Hirata, Akiyoshi,Nokihara, Kiyoshi,Kawamoto, Yusuke,Bando, Toshikazu,Sasaki, Asuka,Ide, Satoru,Maeshima, Kazuhiro,Kasama, Takeshi,Sugiyama, Hiroshi

, p. 11546 - 11554 (2014)

A polyamide containing N-methylpyrrole (Py) and N-methylimidazole (Im), designated PIPA, binds with high affinity and specificity to specific nucleotide sequences in the minor groove of double-helical DNA. Based on a recent report of the synthesis of PIPA for telomere visualization, the present paper focused on the size of the connecting part (hinge region) of two PIPA segments of the tandem hairpin PIPA, Dab(Im-Im-Py)-Py-Py-Py-Im-[Hinge]-Dab(Im-Im-Py)-Py-Py-Py- Im-βAla-NH(CH2)3N(CH3)-(CH 2)3NH-[Dye]. The present paper also describes the characterization of binding by measuring the thermal melting temperature and surface plasmon resonance and by specific staining of telomeres (TTAGGG)n in human cells. Microheterogeneity was also investigated by high-resolution mass spectrometry. We found that the optimal compound as the hinge segment for telomere staining was [-NH(C2H4O)2(C 2H4)CO-] with tetramethylrhodamine as the fluorescent dye.

Efficient synthesis of Fmoc-protected azido amino acids

Lau, Yu Heng,Spring, David R.

, p. 1917 - 1919 (2011)

The efficient two-step synthesis of Fmoc-protected L-azidoalanine and L-azidohomoalanine from readily available Fmoc-protected asparagine and glutamine, respectively, is reported. The synthetic route proceeds in good yield, requires no extra purification steps, and can be carried out on gram scale. The resulting azido amino acids are of sufficient purity for solid-phase peptide synthesis, as demonstrated in the synthesis of a model pentapeptide. Georg Thieme Verlag Stuttgart New York.

Total and Semisyntheses of Polymyxin Analogues with 2-Thr or 10-Thr Modifications to Decipher the Structure-Activity Relationship and Improve the Antibacterial Activity

Li, Jian,Guan, Dongliang,Chen, Feifei,Shi, Weiwei,Lan, Lefu,Huang, Wei

, p. 5746 - 5765 (2021/06/01)

Herein, we report the total and semisyntheses of a series of polymyxin analogues with 2-Thr and 10-Thr modifications to reveal the structure-activity relationship (SAR), which has not been fully elucidated previously. We employed two total-synthetic strategies to facilitate the diversified replacements on 2-Thr or 10-Thr, respectively. Moreover, semisynthetic approaches were utilized to achieve selective esterification of 2-Thr or dual esterification of both 2- and 10-Thr. Based on the results of in vitro antibacterial assays, SAR analysis implicated that the replacement of 2-/10-Thr with amino acids carrying hydrophobic side chains can maintain the activity against Pseudomonas aeruginosa but had varied effects on other tested Gram-negative bacteria. The aminoacetyl esterification on 2-/10-Thr achieved excellent antibacterial activity, and the compound 76 exhibited 2-8-fold higher activity against different strains and lower toxicity toward the HK-2 cell line. This work explored the SAR of polymyxin 2-/10-Thr and provided a promising strategy for the development of novel polymyxin derivatives.

Preparation method of N alpha-fluorenylmethoxycarbonyl-N gamma-(4, 4-dimethyl-2,6-dioxocyclohexylidene) ethyl-butyric acid

-

Paragraph 0017-0021, (2019/10/17)

The invention provides a preparation method of (2S)-4-[[1-(4,4-dimethyl-2,6-dioxocyclohexylidene) ethyl] amino]-2-[[(9H-fluoren-9-ylmethoxy) carbonyl] amino] butyric acid, and mainly solves the technical problems that an existing preparation method is com

Optimized syntheses of Fmoc azido amino acids for the preparation of azidopeptides

Pícha, Jan,Budě?ínsky, Milo?,Machá?ková, Kate?ina,Collinsová, Michaela,Jirá?ek, Ji?í

, p. 202 - 214 (2017/04/06)

The rise of CuI-catalyzed click chemistry has initiated an increased demand for azido and alkyne derivatives of amino acid as precursors for the synthesis of clicked peptides. However, the use of azido and alkyne amino acids in peptide chemistry is complicated by their high cost. For this reason, we investigated the possibility of the in-house preparation of a set of five Fmoc azido amino acids: β-azido l-alanine and d-alanine, γ-azido l-homoalanine, δ-azido l-ornithine and ω-azido l-lysine. We investigated several reaction pathways described in the literature, suggested several improvements and proposed several alternative routes for the synthesis of these compounds in high purity. Here, we demonstrate that multigram quantities of these Fmoc azido amino acids can be prepared within a week or two and at user-friendly costs. We also incorporated these azido amino acids into several model tripeptides, and we observed the formation of a new elimination product of the azido moiety upon conditions of prolonged couplings with 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate/DIPEA. We hope that our detailed synthetic protocols will inspire some peptide chemists to prepare these Fmoc azido acids in their laboratories and will assist them in avoiding the too extensive costs of azidopeptide syntheses. Experimental procedures and/or analytical data for compounds 3–5, 20, 25, 26, 30 and 43–47 are provided in the supporting information.

A Nα-fluorenylmethyloxycarbonyl-Nγ-tert-butoxy carbonyl-L-2,4-diamino-butyric acid synthetic method (by machine translation)

-

Paragraph 0014, (2016/10/09)

This invention involves a kind of Nα-fluorenylmethyloxycarbonyl-Nγ-tert-butoxy carbonyl-L-2,4-diamino-butyric acid synthetic method. Mainly solves the problems that the prior method for preparing more existent steps of and avoid the use of palladium carbon cause very difficult problems of processing technology. The technical scheme of the invention is:a kind of Nα-fluorenylmethyloxycarbonyl-Nγ-tert-butoxy-carbonyl-L-2,4-diamino-butyric acid synthetic method, a Nα-fluorenylmethyloxycarbonyl-Nγ-tert-butoxy-carbonyl-L-2,4-diamino-butyric acid synthetic method, its characteristic is to include the following steps: 1st-step reaction, suspension Fmoc-Gln-OH with acetonitrile, ethyl acetate and water mixed solvent, adding diethyla acid iodophenylamino reaction post-processed to obtain Fmoc-Dab-OH; 2nd-step reaction, acetone and Fmoc-Dab-OH under the condition of the water by adding (Boc) 2 O, for adjusting NaOH pH= 7.5-8, by treatment after reaction Fmoc-Dab (Boc)-OH. The present invention provides large-scale production method for Fmoc-Dab (Boc)-OH. (by machine translation)

Strategy for "Detoxification" of a cancer-derived histone mutant based on mapping its interaction with the methyltransferase PRC2

Brown, Zachary Z.,Müller, Manuel M.,Jain, Siddhant U.,Allis, C. David,Lewis, Peter W.,Muir, Tom W.

supporting information, p. 13498 - 13501 (2015/02/02)

The histone methyltransferase PRC2 plays a central role in genomic stability and cellular development. Consequently, its misregulation has been implicated in several cancers. Recent work has shown that a histone H3 mutant, where the PRC2 substrate residue Lys27 is replaced by methionine, is also associated with cancer phenotypes and functions as an inhibitor of PRC2. Here we investigate the mechanism of this PRC2 inhibition through kinetic studies and photo-cross-linking. Efficient inhibition is dependent on (1) hydrophobic lysine isosteres blocking the active site, (2) proximal residues, and (3) the H3 tail forming extensive contacts with the EZH2 subunit of PRC2. We further show that naturally occurring post-translational modifications of the same H3 tail, both proximal and distal to K27M, can greatly diminish the inhibition of PRC2. These results suggest that this potent gain of function mutation may be "detoxified by modulating alternate chromatin modification pathways.

The contribution of the N-terminal structure of polymyxin B peptides to antimicrobial and lipopolysaccharide binding activity

Sakura, Naoki,Itoh, Tatsuya,Uchida, Yoshiki,Ohki, Kazuhiro,Okimura, Keiko,Chiba, Kenzo,Sato, Yuki,Sawanishi, Hiroyuki

, p. 1915 - 1924 (2007/10/03)

To elucidate the N-terminal structure-activity relationships of polymyxin B peptides, seven polymyxin B component peptides, the structures of which having been elucidated, and seven N-terminal fatty acid and/or amino acid deletion analogs were synthesized, and their antimicrobial activities determined. The lipopolysaccharide (LPS) binding activities of synthetic peptides were evaluated using [Dab(Dansyl-Gly)1]-polymyxin B3 (Dab; L-α,γ-diaminobutyric acid) as a fluorescent probe. The results indicated that the fatty acyl moiety was not indispensable for LPS binding, but the C9 fatty acyl groups of polymyxin B peptides contributed to the binding affinity to a slightly greater extent than C8 or C 7. The fatty acyl moieties of polymyxin B contributed greatly to the antimicrobial activity, while the distinct N-terminal structures of polymyxin B1-B6, bearing normal-, iso-, or anteiso-fatty acids, or 3-hydroxy-fatty acid with chain lengths between C7 and C9, did not affect bactericidal potency.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 161420-87-7